| JXHL2300316 | Zibotentan达格列净片 | dapagliflozin;Zibotentan | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-12-20 | | | | | view |
| JXHL2300317 | Zibotentan达格列净片 | dapagliflozin;Zibotentan | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-12-20 | | | | | view |
| CYHS2300693 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-03-04 | | Zhe JIANG HUA HAI Pharmaceutical Co Ltd | | | view |
| CXHL1501518 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-08-20 | 北京深蓝海生物医药科技有限公司 | Beijing Shenlanhai Biological Medicine Technology Co Ltd | Certificate Issued | 2016-08-23 | view |
| JYHB2101224 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-07-01 | | | | | view |
| CXHL1401130 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-08-20 | 江苏豪森药业股份有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2016-03-10 | view |
| JXHS2100009 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-01-23 | | | In Review | 2022-01-26 | view |
| JXHS2000029 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-04-07 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-04-04 | view |
| JXHL1800094 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-08-15 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-12 | view |
| CYHS2301291 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-12 | | Cisen Pharmaceutical Co Ltd | | | view |
| CXHL1501425 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2016-01-05 | 江西施美制药有限公司 | Jiangxi Shimei Pharmaceutical Co Ltd | Certificate Issued | 2016-11-23 | view |
| CYHS2200642 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2022-04-25 | | | | | view |
| CXHL1401775 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-10 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2016-05-19 | view |
| CYHS2200515 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2022-03-31 | | | | | view |
| JYHB2001771 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-09-14 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-09-30 | view |
| JYHS2400017 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2024-04-17 | | | | | view |
| JXHL0800042 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2008-01-29 | | Bristol-Myers Squibb Company | Certificate Issued | 2008-12-02 | view |
| JXHS1900077 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-06-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-06-24 | view |
| JYHS2300105 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-08-19 | | | | | view |
| JYHB1700825 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-11-21 | view |
